Gland Pharma Fundamental Analysis
GLAND
3061.817.30 (-0.56%)
Last updated on 9 Oct, 2026 | 15:51 IST
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Gland Pharma Fundamentals
P/E Ratio
44.76
P/B Ratio
4.75
Div. Yield
0.65
Sector P/E
41.33
Sector P/B
3.47
Sec. Div. Yield
0.53
Gland Pharma Fundamentals is currently trading with a P/E Ratio of 44.76, compared to the sector average of 41.33. Its P/B Ratio stands at 4.75, while the sector’s is 3.47. In terms of returns, the stock offers a Dividend Yield of 0.65%, which is than the sector’s 0.53%.
Gland Pharma Score Card
Price
Expensive
Growth
Moderate
Quality
Good
Management
Good
On its scorecard, Gland Pharma reflects: Price – Expensive, Growth – Moderate, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in GLAND
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC